Price Alert

XOMA Royalty Corp. (XOMA)

NASDAQ: XOMA · Real-Time Price · USD

32.11

0.37 (1.17%)

At close: Aug 19, 2025, 11:44 AM

1.17% (1D)

Bid	31.67
Market Cap	381.75M
Revenue (ttm)	36.54M
Net Income (ttm)	-2.86M
EPS (ttm)	-1.42
PE Ratio (ttm)	-22.61
Forward PE	82.97
Analyst	Buy

Ask	32.26
Volume	2,841
Avg. Volume (20D)	54,084
Open	31.32
Previous Close	31.74
Day's Range	31.08 - 32.16
52-Week Range	18.35 - 35.00
Beta	1.00

About XOMA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol XOMA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for XOMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

XOMA Royalty has released their quartely earnings on Aug 13, 2025:

Revenue of $13.13M exceeds estimates by $3.72M, with 18.43% YoY growth.

EPS of 0.44 exceeds estimates by 0.58, with 257.14% YoY growth.

Next Earnings Release

XOMA Royalty Corp. is scheduled to release its earnings on Nov 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

8 months ago

-3.05%

XOMA Royalty shares are trading higher after the c... Unlock content with Pro Subscription

News

18 hours ago · zacks.com

How Much Upside is Left in XOMA Royalty (XOMA)? Wall Street Analysts Think 106.15%

The average of price targets set by Wall Street analysts indicates a potential upside of 106.2% in XOMA Royalty (XOMA). While the effectiveness of this highly sought-after metric is questionable, the ...

5 days ago · zacks.com

XOMA Royalty (XOMA) Q2 Earnings and Revenues Surpass Estimates

XOMA Royalty (XOMA) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of a loss of $0.12 per share. This compares to a loss of $0.28 per share a year ago.

1 week ago · businesswire.com

HILLEVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Hille...

1 month ago · seekingalpha.com

Collect Up To 11.5% From The Healthcare Sector

Make your portfolio income-producing and provide valuable cash for your daily life. Aim to be healthy and have the money you need when emergencies arise. America is getting older. Healthcare income op...

1 month ago · zacks.com

XOMA Royalty (XOMA) Moves 9.0% Higher: Will This Strength Last?

XOMA Royalty (XOMA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more streng...